Phytoestrogens and bone health

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 6, 2010, Pages 546-553

  Lagari, Violet S ^a,c   Levis, Silvina ^b,c  

^a Department of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

bone; menopause; osteoporosis; phytoestrogens; soy isoflavones

Indexed keywords

CALCIUM; DAIDZEIN; GENISTEIN; ISOFLAVONE; PHYTOESTROGEN; VITAMIN D;

AGE DISTRIBUTION; ASIA; BONE DENSITY; BONE DISEASE; BONE TURNOVER; CLINICAL TRIAL; DIETARY INTAKE; DRUG MEGADOSE; FRACTURE; HUMAN; LOW DRUG DOSE; NONHUMAN; OSTEOLYSIS; POSTMENOPAUSE; PREMENOPAUSE; REVIEW; SOYBEAN;

ANIMALS; BONE AND BONES; DIETARY SUPPLEMENTS; FEMALE; FUNCTIONAL FOOD; HEALTH STATUS; HUMANS; ISOFLAVONES; MALE; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOESTROGENS; SOY FOODS;

EID: 78649327467     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32833f4867     Document Type: Review

References (54)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288:321-323.
2. Wei F, Miglioretti DL, Connelly MT, et al. Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr 2005; 35: 106-112.
3. Kupferer EM, Dormire SL, Becker H. Complementary and alternative medicine useforvasomotorsymptomsamongwomenwho havediscontinued hormone therapy. J Obstet Gynecol Neonatal Nurs 2009; 38:50-59.
4. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol: a clue to the effectiveness of soy and its isoflavones. J Nutr 2002; 132:3577-3584.
5. Brynin R. Soy and its isoflavones: a review of their effects on bone density. Altern Med Rev 2002; 7:317-327.
6. Joannou GE, Kelly GE, Reeder AY, et al. A urinary profile study of dietary phytoestrogens: the identification and mode of metabolism of new isoflavo-noids.J Steroid Biochem Mol Biol 1995; 54:167-184.
7. Horiuchi T, Onouchi T, Takahashi M, et al. Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteopor Int 2000; 11:721-724.
8. Mei J, Yeung SSC, Kung AWC. High dietary phytoestrogen intake is asso-ciated with higher bone mineral density in postmenopausal but not preme-nopausal women. J Clin Endocrinol Metab 2001; 86:5217-5221.
9. Ho SC, Woo J, Lam S, et al. Soy protein consumption and bone mass in early postmenopausal Chinese women. Osteoporosis Int 2003; 14:835-842.
10. Ikeda Y, Iki M, Morita A, et al. Intake of fermented soybeans, Natto, is associated with reduced bone loss in postmenopausal women: Japanese population-based osteoporosis study. J Nutr 2006; 136:1323-1328.
11. Kim MK, Chung BC, Yu VY, et al. Relationships of urinary phyto-estrogen excretion to BMD in postmenopausal women. Clin Endocrinol 2002; 56: 321-328.
12. Zhang X, Shu X, Li H, et al. Prospective cohortstudyofsoyfood consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 2005; 165:1890-1895.
13. Greendale GA, Fitzgerald G, Huang M, et al. Dietary soy isoflavones and bone mineral density: results from the Study of Women's Health Across the Nation. Am J Epidemiol 2002; 155:746-754.
14. Kritz-Silverstein D, Goodman-Gruen DL. Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women. J Womens Health Gend Based Med 2002; 11:69-78.
15. Chiechi LM, Secreto G, D'Amore M, et al. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Ma-turitas 2002; 42:295-300. (Pubitemid 35007323)
16. Lydeking-Olsen E, Beck-Jensen JE, Setchell KD, Holm-Jensen T. Soymilkor progesterone for prevention of bone loss: a 2-year randomized, placebo-controlled trial. Eur J Nutr 2005; 43:246-257.
17. Roudsari AH, Tahbaz F, Hossein-Nezhad A, et al. Assessment of soy phy-toestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial. Nutr J 2005; 4:30.
18. Wu J, Oka J, Tabata I, et al. Effects of isoflavone and exercise on BMD and fat mass in postmenopausal Japanese women: a 1-year randomized placebo-controlled trial. J Bone Min Res 2006; 21:780-789.
19. Wong WW, Lewis RD, Steinberg FM, et al. Soy isoflavone supplementation and bone mineraldensity in menopausal women:a2-y multicenterclinical trial. Am J Clin Nutr 2009; 90:1433-1439.
20. Albertazzi P, Steel A, Bottazzi M. Effect of pure genistein on bone markers and hot flushes. Cimacteric 2005; 8:371-379.
21. Alekel DL, Van Loan MD, Koehler KJ, et al. The Soy Isoflavones for Reducing Bone Loss (SIRBL) Study: a 3-y randomized controlled trial in postmeno-pausal women. Am J Clin Nutr 2010; 91:218-230.
22. Harkness LS, Fiedler K, Seghal AR, et al. Decreased bone resorptionwith soy isoflavone supplementation in postmenopausal women. J Womens Health 2004; 13:1000-1007.
23. Kenny AM, Mangamo KM, Abourizk RH, et al. Soy proteins and isoflavones affectbone mineral density in olderwomen: arandomized controlled trial. Am J Clin Nutr 2009; 90:234-242.
24. Huang HY, Yang HP, Yang HT, et al. One-year soy isoflavone supplementa-tion prevents early postmenopausal bone loss butwithout a dose-dependent effect. J Nutr Biochem 2006; 17:509-516.
25. Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a rando-mized double-blind placebo-controlled study. J Bone Min Res 2002; 17:1904-1912.
26. Marini H, Minutoli L, Polito F, et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women. Ann Int Med 2007; 146:839-847.
27. Marini H, Minutoli L, Polito F, et al. OPGand sRANKLserum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. J Bone Min Res 2008; 23:715-720.
28. Ye YB, Tang XY, Verbruggen MA, et al. Soy isoflavones attenuate bone loss in early postmenopausal Chinese women: a single-blind randomized, placebo-controlled trial. Eur J Nutr 2006; 45:327-334.
29. Chen YM, Ho SC, Lam SSH, et al. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind randomized controlled trial. J Clin Endocrinol Metab 2003; 88:4740-4747.
30. Chen YM, Ho SC, Lam DDH, et al. Beneficial effectofsoy isoflavone on bone mineral content modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial. Menopause 2004; 11:246-254.
31. Uesugi T, Yuta F, Yamori Y. Beneficial effects of soybean isoflavone supple-mentation on bone metabolism and serum lipids in postmenopausal Japanese women: afour-weekstudy. J Am Coll Nutr 2002; 21:97-102.
32. 41Ca methodology. J Clin Endocrinol Metab 2009; 94:3798-3805.
33. Wu J, Oka J, Ezako J, et al. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause 2007; 14:866-874.
34. Mori M, Aizawa T, Tokoro M, et al. Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middle-aged Japanese women. Clin Exper Phar-macol Physiol 2004; 31:44-46.
35. Lewiecki EM. Premenopausal bone health assessment. Curr Rheumatol Rep 2005; 7:46-52.
36. Levis S, Strickman-Stein N, Doerge DR, Krischer J. Design and baseline characteristics of the Soy Phytoestrogens As Replacement Estrogen (SPARE) Study: a clinical trial of the effects of soy isoflavones in menopausal women. Contemp Clin Trials 2010; 31:293-302.
37. Vupadhyayula PM, Gallagher JC, Templin T, et al. Effectsofsoy protein isolate on bone mineral density and physical performance indices in postmenopausal women: a 2-year randomized, double-blinded, placebo-controlled trial. Menopause 2009; 16:320-328.
38. Gallagher JC, Satpathy R, Raffert K, et al. The effect of soy protein isolate on bone metabolism. Menopause 2004; 11:290-298.
39. 41Ca. J Clin Endocrinol Metab 2007; 92:577-582.
40. Bunout D, Barrera G, Leiva L, et al. Effect of a nutritional supplementation on bone health in Chilean elderly subjects with femoral osteoporosis. Am Coll Nutr 2006; 25:170-177.
41. Evans EM, Racette SB, Van Pelt RE, et al. Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmeno-pausal women. Menopause 2007; 14:481-488.
42. Arjmandi BH, Lucas EA, Khalil DA, et al. One year soy protein supplementa-tion has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr J 2005; 4:30.
43. Wangen KE, Duncan AM, Merz-Demlow BE, et al. Effects of soy isoflavones on markers of bone turnover and postmenopausal women. J Clin Endocrinol Metab 2000; 85:3043-3048.
44. Brink E, Coxam V, Robins S, et al. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled trial. Am J Clin Nutr 2008; 87:761-770.
45. Krejikamp-Kaspers S, Kok L, Grobbee DE, et al. Effect of soy protein contain-ing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women. JAMA 2004; 292:65-74.
46. Frankenfeld CL, McTiernan A, Thomas WK, et al. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Matur-itas 2006; 53:315-324. (Pubitemid 43163067)
47. Yamori Y, Moriguchi EH, Teramoto T, et al. Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil: a ten week study. Am Coll Nutr 2002; 21:560-563.
48. Newton KM, LaCroix AZ, Levy L, et al. Soy protein and bone mineral density in older men and women: a randomized trial. Maturitas 2006; 55:270-277.
49. Potter SM, Baum JA, Teng H, et al. Soy protein and isoflavones: their effects on blood lipids and bone mineral density in postmenopausal women. Am J Clin Nutr 1998; 68:1375-1379.
50. Ross PD, Norimatsu H, Davis JW, et al.Acomparison of hipfracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol 1991; 133:801-809.
51. Adlercreutz H, Mazur W. Phytoestrogens and western diseases. Ann Med 1997; 29:95-120.
52. Ma D, Qin L, Wang P, et al. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr 2008; 27:57-64.
53. Liu J, Ho SC, Su Y, et al. Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials. Bone 2009; 44:948-953.
54. Taku L, Melby MK, Takebayashi J, et al. Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr 2010; 10:33-42.